Azora Therapeutics: Funding, Investors & Team (Sep 2026)
Azora Therapeutics develops therapeutic medicines to treat serious, debilitating inflammatory diseases. It specializes in developing novel small-molecule chemical entities for the treatment of autoimmune and inflammatory diseases like hidradenitis suppurativa (HS) and ulcerative colitis (UC).
Azora Therapeutics has raised $580k across 1 funding round on record, the most recent an undisclosed round of $580k announced in Aug 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Azora Therapeutics Company Profile and Key Stats
Latest funding round on record: Aug 2023.
Azora Therapeutics Funding Rounds
Azora Therapeutics Founders and Leadership Team
Contact details for the Azora Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Azora Therapeutics Funding Compared to Other Biotechnology Startups
Azora Therapeutics' latest round of $580k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Azora Therapeutics in Biotechnology and Los Angeles
Companies Similar to Azora Therapeutics
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Azora Therapeutics Funding FAQs
What does Azora Therapeutics do?
Azora Therapeutics develops therapeutic medicines to treat serious, debilitating inflammatory diseases. It specializes in developing novel small-molecule chemical entities for the treatment of autoimmune and inflammatory diseases like hidradenitis suppurativa (HS) and ulcerative colitis (UC).
How much funding has Azora Therapeutics raised?
Azora Therapeutics has raised $580k across 1 round on record. The most recent is an undisclosed round of $580k announced in Aug 2023.
When did Azora Therapeutics last raise funding?
Azora Therapeutics' most recent funding round on record is an undisclosed round of $580k, announced in Aug 2023.
Who is the CEO of Azora Therapeutics?
Matt Davidson is listed as CEO at Azora Therapeutics.
Where is Azora Therapeutics headquartered?
Azora Therapeutics is based in Los Angeles, California, United States.
How many employees does Azora Therapeutics have?
Azora Therapeutics is in the 1-10 employee band.
How does Azora Therapeutics' funding compare to other Biotechnology startups?
Azora Therapeutics' latest round of $580k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Azora Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Azora Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.